Ads
related to: catalent pharma servicesCatalent.com has been visited by 10K+ users in the past month
goodrx.com has been visited by 1M+ users in the past month
"About 50% of US physicians advise patients consult GoodRx." - Fortune
Search results
Results from the Health.Zone Content Network
Catalent, Inc. ( Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, [2] including approximately 2,400 scientists and technicians.
The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S. Federal Trade Commission (FTC) for approval of a $16.5 billion deal to buy manufacturing subcontractor Catalent, a ...
After the deal closes, Novo Holdings will sell three of Catalent's fill-finish sites - in Anagni, Italy; Brussels, Belgium; and Bloomington, Indiana - onto Novo Nordisk for $11 billion.
Catalent's preliminary revenue of $982 million also beat estimates of $939.14 million. (Reporting by Sriparna Roy and Leroy Leo in Bengaluru; Editing by Pooja Desai and Maju Samuel) Show comments
Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation 's assets, which in 2023 was worth almost DKK 1,114 billion. [2] [3] [4] Danish Kroner (approximately US$163 billion ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
By Patrick Wingrove. (Reuters) -U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a ...
The AstraZeneca vaccine uses a common cold-causing chimpanzee adenovirus, or a vector, to transport some of the spike protein in DNA to your cells. Your cells then take that DNA and convert it ...